Trials / Completed
CompletedNCT02888210
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
Open Label, Phase/3 Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Santen Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate safety and efficacy of MD-15 intraocular lens implanted into the aphakic eyes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MD-15 Intraocular Lens |
Timeline
- Start date
- 2016-09-03
- Primary completion
- 2017-11-22
- Completion
- 2017-11-22
- First posted
- 2016-09-02
- Last updated
- 2018-02-27
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02888210. Inclusion in this directory is not an endorsement.